Company News
Director dealings: Playtech CEO picks up shares, RS Group non-exec invests
Playtech found itself on the list of director buys on Friday, after its chief executive officer spent almost £0. 3m on shares.
Pelatro earnings fall in 'disappointing' year
Marketing software specialist Pelatro reported revenue of $5. 4m in its final results on Friday, down from $7. 3m in 2021.
XLMedia confident despite first-half softness
Digital media company XLMedia said in an update on Friday that the first half of 2023 was expected to see lower revenues compared to the same period in 2022, mainly due to the absence of the highly-anticipated launch of online sports betting in New York state.
Meta to limit ad data use to appease UK competition concerns
Meta Platforms has offered to make changes to the way it uses advertising data from other businesses, it was confirmed on Friday, as it looks to appease concerns flagged by the UK competition watchdog.
Cazoo debtholders enlist bankers ahead of crunch talks - report
Lenders to online car retailer Cazoo have reportedly enlisted bankers to spearhead talks with the company about a £510m debt restructuring.
Quantum Blockchain hires new mining and hardware-focussed manager
Quantum Blockchain announced the appointment of Vladimir Kusznirczuk as its marketing and business development manager on Friday, focusing on expanding opportunities with major Bitcoin miners and mining rig manufacturers in the US and Canada.
Prospex upbeat on outlook as total assets surge
Prospex Energy reported a significant increase in total assets in its final results on Friday, reaching £16. 06m, compared to £6. 7m in 2021.
Pan African lowers full-year production guidance, announces fatality
South African gold miner Pan African Resources downwardly-revised its production guidance for the financial year ending 30 June on Friday, alongside the imminent start of construction at the Mintails project.
Revolution Beauty finally reports 2022 numbers, swings to loss
Revolution Beauty Group finally published its audited results for the year ended 28 February 2022 on Friday, with its results coming in seriously below previous expectations after concerns were raised by its auditors last year.
Simpson retiring as Brickability CEO, board taps Michelmersh chief
Construction materials company Brickability announced on Friday that chief executive officer Alan Simpson had decided to retire from his role, and step down as a director.
Asda and EG poised to agree £10bn merger - report
Asda is set to announce a £10bn merger with sister business EG Group, the petrol stations giant, it was reported on Friday.
New OnTheMarket CFO to take up post in July
OnTheMarket updated the market on the appointment of its new chief financial officer on Friday.
Profits soar at Hurricane as oil prices rocket
North Sea specialist Hurricane Energy reported a surge in annual profits on Friday, as oil prices hit record highs.
US FDA gives priority to Hutchmed's colorectal cancer treatment
Hutchmed China, in collaboration with Takeda, announced on Friday that the US Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) of fruquintinib.
BA cancels more than 50 flights after more computer chaos
British Airways has cancelled at least 50 Heathrow flights at the start of the Bank holiday weekend due to a computer problem affecting online check in.
Asos raises £75m through share placing
Fast fashion retailer Asos has raised £75m from shareholders, it confirmed on Friday, as it looks to shore up its finances.
IntegraFin revenue slips in 'robust' first half
Financial services company IntegraFin reported a “robust” first-half performance for its Transact platform on Friday, with net inflows of £1. 6bn.
Kin and Carta cuts full-year revenue guidance
Kin and Carta slumped on Friday as it cut revenue guidance after new business growth slowed.
UKCM sells Wembley180 asset for £74m
UK Commercial Property REIT said it had sold its Wembley180 logistics asset in London to Covent Garden IP for £74m.
AstraZeneca's Imfinzi shows positive results for endometrial cancer patients
AstraZeneca said results from a Phase III trial showed its Imfinzi treatment in combination with chemotherapy showed a significant improvement in patients with endometrial cancer.